Evaluation of Brain Metastases Treated With Stereotactic Radiotherapy Using Dynamic [18F]FDG PET
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Study ID
- NCT06511323
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Brain Metastases
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- dynamic [18-FDG PET] scan post stereotactic radiation for brain metastases — DIAGNOSTIC_TESTat baseline prior to stereotactic radiation, at 10 weeks after treatment, and at first concern for progression at treated lesion or 12 months post-treatment, whichever comes earlier.
Study Details
The purpose of this study is to evaluate the clinical usefulness of dynamic \[18F\]FDG PET imaging in assessing brain metastasis post stereotactic radiotherapy to separate true progression from the treatment-related changes.
Key Dates
- First listed
- Jul 19, 2024
- Start date
- Aug 31, 2024
- Status verified
- Jul 2024
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: ObservationalThis is a prospective, single-arm, pilot diagnostic study to evaluate the diagnostic accuracy of using dynamic \[18F\]FDG PET in 70 patients with brain metastases managed with stereotactic radiosurgery(SRS)/fractionated stereotactic radiotherapy (FSRT). The study will include imaging assessments at baseline, at 10 weeks after treatment, and at first concern for progression or 12 months post-treatment, whichever comes earlier.
Primary Outcome Measure
Diagnostic accuracy of dynamic PET [ Time Frame: 12-month follow-up. ]
Central Contacts
- Maureen Dougan519 685 8500
- Melody Qu519 685 8500
Related Studies
- Stereotactic Radiosurgery Dose Escalation for Brain MetastasesPHASE1 · Recruiting · University of Utah · Salt Lake City, Utah
- Frameless Stereotactic Radiosurgery for Intact Brain MetastasesPHASE2 · Recruiting · University of Chicago · Chicago, Illinois
- Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer PatientsPHASE1/PHASE2 · Recruiting · Weill Medical College of Cornell University · New York, New York
- Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain MetastasesPHASE3 · Recruiting · Canadian Cancer Trials Group · Tucson, Arizona